Prognostic value of FDG‐PET/CT response for patient selection before chimeric antigen receptor‐T‐cells therapy in non‐Hodgkin lymphoma - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Hematological Oncology Year : 2022

Prognostic value of FDG‐PET/CT response for patient selection before chimeric antigen receptor‐T‐cells therapy in non‐Hodgkin lymphoma

Abstract

No abstract available

Domains

Cancer
Embargoed file
Embargoed file
Visibility date is undetermined

Dates and versions

inserm-03561692 , version 1 (08-02-2022)

Identifiers

Cite

Clément Bailly, Thomas Carlier, Benoit Tessoulin, Thomas Gastinne, Françoise Kraeber‐bodere, et al.. Prognostic value of FDG‐PET/CT response for patient selection before chimeric antigen receptor‐T‐cells therapy in non‐Hodgkin lymphoma. Hematological Oncology, 2022, Online ahead of print. ⟨10.1002/hon.2965⟩. ⟨inserm-03561692⟩
40 View
18 Download

Altmetric

Share

Gmail Facebook X LinkedIn More